{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:37:16Z","timestamp":1760150236625,"version":"build-2065373602"},"reference-count":28,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The identification of proteins as new cancer diagnostic and prognostic biomarkers continues to attract considerable attention in the oncology literature, especially in the context of invasion and metastasis activation process [...]<\/jats:p>","DOI":"10.3390\/cancers15205000","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:43:49Z","timestamp":1697435029000},"page":"5000","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biomarkers of Tumor Metastasis and Invasiveness"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0820-3828","authenticated-orcid":false,"given":"Daniel L.","family":"Pouliquen","sequence":"first","affiliation":[{"name":"Inserm, CRCI<sup>2<\/sup>NA, CNRS, Universit\u00e9 d\u2019Angers, Nantes Universit\u00e9, F-49000 Angers, France"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1554-9891","authenticated-orcid":false,"given":"Cristina","family":"N\u00fa\u00f1ez Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Research Unit, Lucus Augusti University Hospital (HULA), Servizo Galego de Saude (SERGAS), 27002 Lugo, Spain"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Veuger, J., Kuipers, N.C., Willems, S.M., and Halmos, G.B. (2023). Tumor markers and their prognostic value in sinonasal ITAC\/Non-ITAC. Cancers, 15.","DOI":"10.3390\/cancers15123201"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Giusti, I., Poppa, G., Di Fazio, G., D\u2019Ascenzo, S., and Dolo, V. (2023). Metastatic dissemination: Role of tumor-derived extracellular vesicles and their use as clinical biomarkers. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119590"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3350\/cmh.2022.0425","article-title":"Neuropilins as potential biomarkers in hepatocellular carcinoma: A systematic review of basic and clinical applications","volume":"29","author":"Mauriz","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Lin, Y., and Cai, H. (2023). Biological functions and therapeutic potential of SHCBP1 in human cancer. Biomed. Pharmacother., 160.","DOI":"10.1016\/j.biopha.2023.114362"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/cells12091314","article-title":"Zinc finger proteins in the war on gastric cancer: Molecular mechanism and clinical potential","volume":"12","author":"Liu","year":"2023","journal-title":"Cells"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pintor-Romero, V.G., Hurtado-Ortega, E., Nicol\u00e1s-Morales, M.L., Guti\u00e9rrez-Torres, M., Vences-Vel\u00e1zquez, A., Ortu\u00f1o-Pineda, C., Espinoza-Rojo, M., Navarro-Tito, N., and Cort\u00e9s-Sarabia, K. (2023). Biological role and aberrant overexpression of syntenin-1 in cancer: Potential role as a biomarker and therapeutic target. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041034"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Carrasco-Garcia, E., Lopez, L., Moncho-Amor, V., Carazo, F., Aldaz, P., Collado, M., Bell, D., Gaafar, A., Karamitopoulou, E., and Tzankov, A. (2022). SOX9 triggers different epithelial to mesenchymal transition states to promote pancreatic cancer progression. Cancers, 14.","DOI":"10.3390\/cancers14040916"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tozuka, T., Noro, R., Seike, M., and Honda, K. (2022). Benefits from adjuvant chemotherapy in patients with resected non-small cell lung cancer: Possibility of stratification by gene amplification of ACTN4 according to evaluation of metastatic ability. Cancers, 14.","DOI":"10.3390\/cancers14184363"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Rao, I.H., Waller, E.K., Dhamsania, R.K., and Chandrasekaran, S. (2023). Gene expression analysis links autocrine vasoactive intestinal peptide and ZEB1 in gastrointestinal cancers. Cancers, 15.","DOI":"10.3390\/cancers15133284"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wu, Q., Tsai, H.-I., Zhu, H., and Wang, D. (2022). The entanglement between mitochondrial DNA and tumor metastasis. Cancers, 14.","DOI":"10.3390\/cancers14081862"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pouliquen, D.L., Ortone, G., Rumiano, L., Boissard, A., Henry, C., Blandin, S., Guette, C., Riganti, C., and Kopecka, J. (2023). Long-chain acyl coenzyme A dehydrogenase, a key player in metabolic rewiring\/invasiveness in experimental tumors and human mesothelioma cell lines. Cancers, 15.","DOI":"10.20944\/preprints202305.0978.v1"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Oba, M., Nakanishi, Y., Mitsuhashi, T., Sasaki, K., Hatanaka, K.C., Sasaki, M., Nange, A., Okumura, A., Hayashi, M., and Yoshida, Y. (2023). CCR7 mediates cell invasion and migration in extrahepatic cholangiocarcinoma by inducing epithelial-mesenchymal transition. Cancers, 15.","DOI":"10.3390\/cancers15061878"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Huang, L., Sun, F., Liu, Z., Jin, W., Zhang, Y., Chen, J., Zhong, C., Liang, W., and Peng, H. (2023). Probing the potential of defense response-associated genes for predicting the progression, prognosis, and immune microenvironment of osteosarcoma. Cancers, 15.","DOI":"10.3390\/cancers15082405"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sun, H., Wang, H., Pan, H., Zuo, Y., Zhao, R., Huang, R., Xue, Y., and Song, H. (2023). CD19 (+) B cell combined with prognostic nutritional index predicts the clinical outcomes of patients with gastric cancer who underwent surgery. Cancers, 15.","DOI":"10.3390\/cancers15092531"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.semcancer.2022.11.004","article-title":"Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma","volume":"87","author":"Rackles","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sareen, H., Ma, Y., Becker, T.M., Roberts, T.L., de Souza, P., and Powter, B. (2022). Molecular biomarkers in glioblastoma: A systematic review and meta-analysis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23168835"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Marshland, M., Dowdell, A., Faulkner, S., Gedye, C., Lynam, J., Griffin, C.P., Marshland, J., Jiang, C.C., and Hondermarck, H. (2023). The membrane protein sortilin is a potential biomarker and target for glioblastoma. Cancers, 15.","DOI":"10.3390\/cancers15092514"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jiang, C., Zhao, M., Hou, S., Hu, X., Huang, J., Wang, H., Ren, C., Pan, X., Zhang, T., and Wu, S. (2022). The indicative value of serum tumor markers for metastasis and stage of non-small cell lung cancer. Cancers, 14.","DOI":"10.3390\/cancers14205064"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dunphy, K., Bazou, D., Henry, M., Meleady, P., Miettinen, J.J., Heckman, C.A., Dowling, P., and O\u2019Gorman, P. (2023). Proteomic and metabolomic analysis of bone marrow and plasma from patients with extramedullary multiple myeloma identifies distinct protein and metabolite signatures. Cancers, 15.","DOI":"10.3390\/cancers15153764"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chen, L.-M., and Chai, K.X. (2023). Exosome-mediated activation of the prostasin-matriptase serine protease cascade in B lymphoma cells. Cancers, 15.","DOI":"10.3390\/cancers15153848"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"\u0141ukaszewicz-Zaj\u0105c, M., P\u0105czek, S., and Mroczko, B. (2022). A disintegrin and metalloproteinase (ADAM) family\u2014Novel biomarkers of selected gastrointestinal (GI) malignancies?. Cancers, 14.","DOI":"10.3390\/cancers14092307"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"154220","DOI":"10.1016\/j.prp.2022.154220","article-title":"CD47 mediates the progression of colorectal cancer by inducing tumor cell apoptosis and angiogenesis","volume":"240","author":"Oh","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lombaers, M.S., Cornel, K.M.C., Visser, N.C.M., Bulten, J., K\u00fcsters-Vandevelde, H.V.N., Amant, F., Boll, D., Bronsert, P., Colas, E., and Geomini, P.M.A.J. (2023). Preoperative CA125 significantly improves risk stratification in high-grade endometrial cancer. Cancers, 15.","DOI":"10.3390\/cancers15092605"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yu, F.-Y., Xu, Q., Zhao, X.-Y., Mo, H.-Y., Zhong, Q.-H., Luo, L., Lau, A.T.Y., and Xu, Y.-M. (2023). The atypical MAP kinase MAPK15 is required for lung adenocarcinoma metastasis via its interaction with NF-kB p50 subunit and transcriptional regulation of prostaglandin E2 receptor EP3 subtype. Cancers, 15.","DOI":"10.3390\/cancers15051398"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Klein, M., Wefers, M., Hallermann, C., Fischer, H.J., H\u00f6lzle, F., and Wermker, K. (2023). IMP3 expression as a potential tumour marker in high-risk localisations of cutaneous squamous cell carcinoma: IMP3 in metastatic cSCC. Cancers, 15.","DOI":"10.3390\/cancers15164087"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Shi, F., Wei, B., Lan, T., Xiao, Y., Quan, X., Chen, J., Zhao, C., and Gao, J. (2021). Low NLRP3 expression predicts a better prognosis of colorectal cancer. Biosci. Rep., 41.","DOI":"10.1042\/BSR20210280"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"705331","DOI":"10.3389\/fonc.2021.705331","article-title":"Prognostic value of NLRP3 inflammasome and TLR4 expression in breast cancer patients","volume":"11","author":"Saponaro","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Casili, G., Scuderi, S.A., Lanza, M., Filippone, A., Mannino, D., Giuffrida, R., Colarossi, C., Mare, M., Capra, A.P., and De Gaetano, F. (2023). Therapeutic potential of BAY-117082, a selective NLRP3 inflammasome inhibitor, on metastatic evolution in human oral squamous cell carcinoma (OSCC). Cancers, 15.","DOI":"10.3390\/cancers15102796"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/20\/5000\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:07:26Z","timestamp":1760130446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/20\/5000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":28,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["cancers15205000"],"URL":"https:\/\/doi.org\/10.3390\/cancers15205000","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2023,10,16]]}}}